Tivic Health Systems Inc (NASDAQ: TIVC) — Healthcare · Share Price, Chart & Market Data
About: Valion Bio, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Sector: Healthcare
Industry: Medical Devices
Latest price: $1.01 (-27.86%)
TIVCTivic Health Systems Inc
Loading watchlist status…
Trade TIVC now
Tivic Health Systems Inc share price
TIVC price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
30 Apr, 6:51 am GMT+0
TIVC price performance
-9.821%
5D
18.824%
1M
-28.873%
YTD
-78.091%
1Y
TIVC price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
30 Apr, 6:51 am GMT+0
TIVC details
TIVC Market Signals